Related by context. Frequent words. (Click for all words.) 68 evaluable 68 evaluable patients 66 docetaxel 66 gemcitabine 65 advanced NSCLC 65 trastuzumab 65 bevacizumab 64 carboplatin 64 secondary endpoint 63 bortezomib 63 erlotinib 63 tumor shrinkage 62 sunitinib 62 rituximab 61 5 FU 61 cetuximab 61 adjuvant therapy 60 capecitabine 60 gefitinib 60 primary endpoint 60 imatinib 60 temozolomide 60 adjuvant chemotherapy 60 monotherapy 60 metastatic colorectal cancer 60 sorafenib 59 dasatinib 59 brain metastases 59 p = #.# [004] 59 melphalan 59 pegylated interferon 58 5 fluorouracil 58 tumor recurrence 58 lenalidomide 58 infliximab 58 anastrozole 58 HCV RNA 58 metastatic melanoma 57 primary efficacy endpoint 57 etanercept 57 chemotherapy regimen 57 cisplatin 57 FOLOTYN 57 IMGN# 57 NSCLC 57 antitumor activity 57 secondary endpoints 57 confidence interval CI 57 oxaliplatin 57 metastatic prostate cancer 56 chemotherapy regimens 56 Vectibix 56 metastatic disease 56 mg/m2 56 hormone refractory prostate cancer 56 lamivudine 56 ipilimumab 56 relapsing remitting multiple sclerosis 56 zoledronic acid 56 mg dose 56 disease progression 56 p = #.# [002] 56 statistically significant improvement 56 CYPHER R Stent 55 panitumumab 55 ofatumumab 55 tolerability 55 cytarabine 55 doxorubicin 55 irinotecan 55 dexamethasone 55 pioglitazone 55 placebo 55 bone metastases 55 PROVENGE 55 clinically meaningful 55 follicular lymphoma 55 RG# [001] 55 cyclophosphamide 55 tolerability profile 55 letrozole 54 copies mL 54 lapatinib 54 demonstrated statistically significant 54 T DM1 54 clopidogrel 54 ACTEMRA 54 methotrexate 54 renal function 54 anti TNF 54 placebo p 54 FTY# 54 HER2 positive breast cancer 53 pharmacodynamic 53 mg kg 53 copies ml 53 rosuvastatin 53 paclitaxel 53 TMC# [001] 53 carfilzomib 53 dose escalation